Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03107949 · ClinicalTrials.gov registry record · NA
Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing (RESCUE1)
A NA study, sponsored by Lungpacer Medical.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03107949 is a NA study that has completed, run by Lungpacer Medical. The registered enrollment target is 9 participants.
The verdict
NCT03107949, a NA study, has completed, sponsored by Lungpacer Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
An early feasibility study to investigate the safety and feasibility of the Lungpacer Diaphragm Pacing Therapy System (DPTS) as a therapy to recondition and strengthen the diaphragm of patients who have been intubated and invasively mechanically ventilated for \> or = 7 days, have failed two or more spontaneous breathing trials (SBT), and were not hypervolemic during the latest SBT.
Interventions
- DEVICE Lungpacer DPTS (Diaphragm Pacing Therapy System)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-06-20 |
| Est. Completion | 2018-02-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03107949
The ClinicalTrials.gov registry entry for NCT03107949 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lungpacer Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lungpacer DPTS (Diaphragm Pacing Therapy System) is the first listed.
NCT03107949 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03107949 about?
NCT03107949 is a clinical study titled "Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing (RESCUE1)". An early feasibility study to investigate the safety and feasibility of the Lungpacer Diaphragm Pacing Therapy System (DPTS) as a therapy to recondition and strengthen the diaphragm of patients who have been intubated and invasively mechanically ventilated for \> or = 7 days, have failed two or more...
What is the current status of trial NCT03107949?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2017-06-20. Estimated completion is 2018-02-18.
What interventions are being tested in trial NCT03107949?
The interventions under investigation include: Lungpacer DPTS (Diaphragm Pacing Therapy System) (DEVICE).
Who is sponsoring clinical trial NCT03107949?
This trial is sponsored by Lungpacer Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.